Search Results 811-820 of 18128 for monoclonal antibody

  1. Science Saturday: Antibody testing, in pictures - Mayo Clinic News Network

    Convalescent plasma therapy for the treatment of COVID-19 virus infection is based on the function of antibodies, tiny proteins created by the immune system ...

  2. Neurology - Clinical trials - Mayo Clinic

    Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ...

  3. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  4. Mantle Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...

  5. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  6. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  7. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers - Mayo Clinic

    Participation eligibility · Must be at least 4 weeks (for FL) or 2 weeks (for DLBCL) since prior cytotoxic, biologic, monoclonal antibody, or investigational ...

  8. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  9. Mayo Clinic Q and A: Treatment options for migraine

    The first calcitonin gene-related peptide monoclonal antibody to prevent migraine was approved in 2018. Today, four drugs have been approved: Eptinezumab ...

  10. Pembrolizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Pembrolizumab is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...